Latest On VIVUS, Inc (VVUS):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2020-11-26 22:00 EST | Financials | Company financials have been released. | Neutral |  |
| 2020-11-13 13:03 EST | News | Acceleron's sotatercept shows positive action in mid-stage pulmonary arterial hypertension studies | N/A | |
| 2020-11-08 01:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 17:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 14:33 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 06:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 10:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 09:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 18:17 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 06:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 22:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 14:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 18:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 10:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-08 23:02 EST | News | Vivus moves closer to emerging from bankruptcy | N/A | |
| 2020-07-01 18:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 14:01 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 06:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 07:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-09 10:24 EST | News | Vivus files for equity offering | N/A | |
| 2020-06-02 06:13 EST | Earnings Estimate | An EPS average of -$0.51 is estimated for the quarter ending on September 30, 2020. | Sell | |
| 2020-05-27 06:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 02:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-10 06:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-08 00:51 EST | News | Vivus EPS beats by $0.31, beats on revenue | N/A | |
| 2020-05-08 00:50 EST | News | VIVUS, Inc's (VVUS) CEO John Amos on Q1 2020 Results - Earnings Call Transcript | N/A | |
| 2020-05-06 06:49 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 06:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-14 08:15 EST | News | Vivus up 4% premarket on Qsymia launch in Korea | N/A | |
| 2020-04-14 08:00 EST | News | Vivus EPS beats by $0.07, misses on revenue | N/A | |
| 2020-04-14 07:55 EST | News | Vivus -7.6% on filing to offer up to $50M in shares | N/A | |
| 2020-04-14 07:27 EST | News | Vivus up 272% premarket on launch of telemedicine modules | N/A | |
| 2020-04-14 07:26 EST | News | Vivus down 55% on equity offering | N/A | |
| 2020-04-14 07:07 EST | News | VIVUS Finding Support After Launch Of Its Remote Health Platform | N/A | |
| 2020-04-03 22:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-26 21:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-25 21:49 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-06 00:43 EST | Analyst Rating | The Analyst Target Price has decreased from $10 to $1.75. | Sell | |
| 2020-03-04 04:43 EST | Earnings Estimate | An EPS average of -$1.53 is estimated for the 2021 year. | Sell | |
| 2020-03-04 04:43 EST | Earnings Estimate | An EPS average of -$0.66 is estimated for the quarter ending on June 30, 2020. | Sell | |
| 2020-03-03 22:06 EST | News | VIVUS, Inc. (VVUS) CEO John Amos on Q4 2019 Results - Earnings Call Transcript | N/A | |
| 2020-02-28 05:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-27 23:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-22 01:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-18 00:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-13 01:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-08 00:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-07 01:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-01 01:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-01-29 01:02 EST | Financials | Company financials have been released. | Neutral | |
About VIVUS, Inc (VVUS):
VIVUS, Inc. operates as a specialty pharmaceutical company primarily in the United States and the European Union. The company offers Qsymia for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body-mass index of 30 or greater (obese patients) or 27 or greater (overweight patients) in the presence of at least one weight-related comorbidity, such as hypertension, type 2 diabetes mellitus, or high cholesterol. It also provides PANCREAZE to treat exocrine pancreatic insufficiency due to cystic fibrosis, chronic pancreatitis, pancreatic cancer or other conditions; and STENDRA/SPEDRA, an oral phosphodiesterase type 5 inhibitor for erectile dysfunction. In addition, the company is developing Qsymia, which has completed Phase II clinical study for treating various diseases, including obstructive sleep apnea, diabetes, nonalcoholic steatohepatitis, and bariatric surgery; and VI-0106 that has completed Phase IIa study to treat patients with pulmonary arterial hypertension. It has collaboration agreements with Mitsubishi Tanabe Pharma Corporation; Menarini Group; Sanofi; Metuchen Pharmaceuticals, LLC; Selten Pharma, Inc.; and Alvogen Malta Operations (ROW) Ltd. VIVUS, Inc. was founded in 1991 and is headquartered in Campbell, California. On July 7, 2020, VIVUS, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
General
- Name VIVUS, Inc
- Symbol VVUS
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 59
- Last Split Factor1:10
- Last Split Date2018-09-11
- Fiscal Year EndDecember
- IPO Date1994-04-06
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.vivus.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 0.01
- Enterprise Value Revenue 2.88
- Enterprise Value EBITDA 35.19
View More
Financials
- Most Recent Quarter 2020-03-31
- Profit Margin -39%
- Operating Margin -12%
- Return on Assets -2%
- Revenue 73.25 million
- Earnings Per Share -$2.60
- Revenue Per Share $6.88
- Gross Profit 43.83 million
- Quarterly Earnings Growth 21.6%
View More
Highlights
- Market Capitalization 8.34 million
- EBITDA 5.78 million
- PEG Ratio -2.73
- Analyst Target Price $1.75
- Book Value Per Share -$4.93
View More
Share Statistics
- Shares Outstanding 17.87 million
- Shares Float 14.82 million
- % Held by Insiders 709%
- % Held by Institutions 19.07%
- Shares Short 3.01 million
- Shares Short Prior Month 510645
- Short Ratio 3.45
- Short % of Float 17%
- Short % of Shares Outstanding 17%
View More
Technicals
- Beta -0.85
- 52 Week High $1.5
- 52 Week Low $0.07
- 50 Day Moving Average 0.12
- 200 Day Moving Average 0.3
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
View More
VIVUS, Inc (VVUS) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
VIVUS, Inc (VVUS) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-03-31 | 2020-05-06 | $19.63 million | -$0.49 | -$0.80 | 38.75% |
| 2019-12-31 | 2020-03-03 | $17.25 million | -$0.61 | -$0.68 | 10.29% |
| 2019-09-30 | 2019-11-05 | $17.97 million | -$1.04 | -$0.74 | -40.54% |
| 2019-06-30 | 2019-08-06 | $18.39 million | -$0.56 | -$0.99 | 43.43% |
| 2019-03-31 | 2019-04-30 | $16.15 million | -$0.75 | -$1.17 | 35.9% |
| 2018-12-31 | 2019-02-26 | $20.11 million | -$0.42 | -$0.53 | 20.75% |
| 2018-09-30 | 2018-11-01 | $18.09 million | -$0.87 | -$1.11 | 21.62% |
| 2018-06-30 | 2018-08-07 | $14.96 million | -$1.20 | -$1.10 | -9.09% |
| 2018-03-31 | 2018-05-08 | $11.9 million | -$1.00 | -$1.10 | 9.09% |
| 2017-12-31 | 2018-03-13 | $11.94 million | -$1.00 | -$1.30 | 23.08% |
| 2017-09-30 | 2017-11-07 | $15.19 million | -$0.60 | -$1.30 | 53.85% |
| 2017-06-30 | 2017-08-03 | $11.23 million | -$1.30 | -$1.30 | 0% |
| 2017-03-31 | 2017-05-03 | $27.01 million | -$0.10 | -$1.35 | 92.59% |
| 2016-12-31 | 2017-03-08 | $81.81 million | $5.40 | $2.30 | 134.78% |
| 2016-09-30 | 2016-11-09 | $13.35 million | -$0.90 | -$1.85 | 51.35% |
| 2016-06-30 | 2016-08-04 | $13.78 million | -$0.11 | -$0.30 | 63.33% |
| 2016-03-31 | 2016-05-03 | $15.32 million | -$0.12 | -$0.21 | 42.86% |
| 2015-12-31 | 2016-03-09 | $15.34 million | -$0.12 | -$0.12 | 0% |
| 2015-09-30 | 2015-11-04 | $24.94 million | -$0.15 | -$0.17 | 11.76% |
| 2015-06-30 | 2015-07-30 | $22.99 million | -$0.48 | -$0.24 | -100% |
| 2015-03-31 | 2015-05-05 | $32.17 million | -$0.15 | -$0.22 | 31.82% |
| 2014-12-31 | 2015-02-24 | $21.73 million | -$0.25 | -$0.25 | 0% |
| 2014-09-30 | 2014-11-05 | $33.88 million | -$0.15 | -$0.25 | 40% |
| 2014-06-30 | 2014-08-07 | $21.88 million | -$2.50 | -$2.77 | 9.75% |
| 2014-03-31 | 2014-05-05 | $36.69 million | -$1.50 | -$3.66 | 59.02% |
| 2013-12-31 | 2014-02-24 | $44.06 million | -$1.70 | -$3.96 | 57.07% |
| 2013-09-30 | 2013-11-05 | $27.38 million | -$4.80 | -$3.83 | -25.33% |
| 2013-06-30 | 2013-08-06 | $5.53 million | -$5.50 | -$4.38 | -25.57% |
| 2013-03-31 | 2013-05-08 | $4.11 million | -$4.70 | -$5.06 | 7.11% |
| 2012-12-31 | 2013-02-25 | $1.97 million | -$5.60 | -$4.41 | -26.98% |
| 2012-09-30 | 2012-11-06 | $41000 | -$4.00 | -$3.14 | -27.39% |
| 2012-06-30 | 2012-08-07 | $N/A | -$2.40 | -$2.33 | -3% |
| 2012-03-31 | 2012-05-07 | $N/A | -$2.00 | -$1.35 | -48.15% |
| 2011-12-31 | 2012-02-28 | $N/A | -$1.40 | -$1.12 | -25% |
| 2011-09-30 | 2011-11-07 | $N/A | -$1.00 | -$1.25 | 20% |
| 2011-06-30 | 2011-08-01 | $N/A | -$2.00 | -$1.32 | -51.52% |
| 2011-03-31 | 2011-05-02 | $N/A | -$1.20 | -$1.52 | 21.05% |
| 2010-12-31 | 2011-02-28 | $N/A | -$2.30 | -$2.19 | -5.02% |
| 2010-09-30 | 2010-11-08 | $N/A | -$2.20 | -$2.69 | 18.22% |
| 2010-06-30 | 2010-08-02 | $N/A | -$2.80 | -$2.35 | -19.15% |
| 2010-03-31 | 2010-05-03 | $N/A | -$2.30 | -$2.58 | 10.85% |
| 2009-12-31 | 2010-03-08 | $50.04 million | -$1.60 | -$2.50 | 36% |
| 2009-09-30 | 2009-11-03 | $-9163000 | -$3.00 | -$3.10 | 3.23% |
| 2009-06-30 | 2009-07-31 | $9.16 million | -$1.90 | -$1.76 | -7.95% |
| 2009-03-31 | 2009-05-11 | $22.23 million | -$1.00 | -$0.69 | -44.93% |
| 2008-12-31 | 2009-03-09 | $28.8 million | -$1.00 | -$0.01 | -9900% |
| 2008-09-30 | 2008-11-04 | $25.48 million | $0.04 | $0.06 | -34.67% |
| 2008-06-30 | 2008-08-04 | $25.27 million | $0.60 | -$0.33 | 281.82% |
| 2008-03-31 | 2008-05-08 | $22.69 million | -$1.20 | $0.80 | -250% |
| 2007-12-31 | 2008-03-06 | $29.82 million | $1.70 | $2.03 | -16.26% |
| 2007-09-30 | 2007-11-09 | $19.09 million | $0.20 | $0.03 | 566.67% |
| 2007-06-30 | 2007-08-01 | $4.1 million | -$1.10 | -$0.50 | -120% |
| 2007-03-31 | 2007-04-26 | $1.69 million | -$1.30 | -$1.20 | -8.33% |
| 2006-12-31 | 2007-03-02 | $8.31 million | -$0.20 | -$0.88 | 77.27% |
| 2006-09-30 | 2006-10-26 | $4.03 million | -$1.30 | -$1.36 | 4.41% |
| 2006-06-30 | 2006-07-27 | $3.64 million | -$1.20 | -$1.55 | 22.58% |
| 2006-03-31 | 2006-04-27 | $1.27 million | -$2.00 | -$1.53 | -30.72% |
| 2005-12-31 | 2006-02-23 | $9.04 million | -$0.20 | -$0.55 | 63.64% |
| 2005-09-30 | 2005-10-26 | $3.27 million | -$1.30 | -$1.55 | 16.13% |
| 2005-06-30 | 2005-07-28 | $1.72 million | -$1.90 | -$1.75 | -8.57% |
| 2005-03-31 | 2005-04-28 | $629000 | -$2.20 | -$2.00 | -10% |
| 2004-12-31 | 2005-01-27 | $10.13 million | -$0.20 | -$0.70 | 71.43% |
| 2004-09-30 | 2004-10-20 | $4.33 million | -$1.30 | -$0.60 | -116.67% |
| 2004-06-30 | 2004-07-21 | $3.2 million | -$1.30 | -$1.05 | -23.81% |
| 2004-03-31 | 2004-04-29 | $1.94 million | -$2.90 | -$0.60 | -383.33% |
| 2003-12-31 | 2004-01-28 | $8.99 million | $0.60 | -$0.35 | 271.43% |
| 2003-09-30 | 2003-10-22 | $5.5 million | -$0.40 | -$0.80 | 50% |
| 2003-06-30 | 2003-07-16 | $3.65 million | -$0.80 | -$1.00 | 20% |
| 2003-03-31 | 2003-04-16 | $4.27 million | -$1.00 | -$1.27 | 21.26% |
| 2002-12-31 | 2003-01-22 | $7.89 million | -$0.50 | -$1.17 | 57.27% |
| 2002-09-30 | 2002-10-16 | $3.53 million | -$1.00 | -$1.23 | 18.7% |
| 2002-06-30 | 2002-07-18 | $4.55 million | -$1.00 | -$0.80 | -25% |
| 2002-03-31 | 2002-04-17 | $6.38 million | -$0.60 | -$0.70 | 14.29% |
| 2001-12-31 | 2002-01-23 | $5.32 million | -$0.05 | -$0.55 | 91.62% |
| 2001-09-30 | 2001-10-17 | $5.55 million | -$0.30 | -$0.50 | 40% |
| 2001-06-30 | 2001-07-18 | $6.37 million | -$0.30 | -$0.10 | -200% |
| 2001-03-31 | 2001-04-18 | $6.36 million | -$1.50 | -$0.40 | -275% |
| 2000-12-31 | 2001-01-24 | $7.3 million | $1.50 | $0.20 | 650% |
| 2000-09-30 | 2000-10-18 | $4.98 million | -$0.20 | $0.15 | -233.33% |
| 2000-06-30 | 2000-07-19 | $6.75 million | $0.30 | $0.10 | 200% |
| 2000-03-31 | 2000-04-19 | $7.47 million | $0.50 | $0.10 | 400% |
| 1999-12-31 | 2000-01-26 | $5.80 | $4.20 | 38.1% | |
| 1999-09-30 | 1999-10-21 | $0.30 | $0.20 | 50% | |
| 1999-06-30 | 1999-07-21 | $0.10 | $0.20 | -50% | |
| 1999-03-31 | 1999-04-21 | $1.20 | $0.40 | 200% | |
| 1998-12-31 | 1999-01-28 | $0.30 | $0.35 | -14.29% | |
| 1998-09-30 | 1998-11-17 | -$5.60 | -$7.60 | 26.32% | |
| 1998-06-30 | 1998-06-30 | -$7.61 | |||
| 1998-03-31 | 1998-04-09 | -$0.70 | -$0.30 | -133.33% | |
| 1997-12-31 | 1998-01-15 | $1.70 | $1.83 | -7.1% | |
| 1997-09-30 | 1997-10-08 | $3.10 | $2.63 | 17.87% | |
| 1997-06-30 | 1997-07-09 | $2.80 | $1.68 | 66.67% | |
| 1997-03-31 | 1997-04-08 | $2.70 | $1.53 | 76.47% | |
| 1996-12-31 | 1997-01-30 | -$2.85 | -$3.02 | 5.63% | |
| 1996-09-30 | 1996-10-17 | $0.75 | $0.18 | 316.67% | |
| 1996-06-30 | 1996-07-18 | -$1.30 | $1.15 | -213.04% | |
| 1996-03-31 | 1996-04-18 | -$2.25 | -$2.30 | 2.17% |
VIVUS, Inc (VVUS) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 |
|---|---|---|---|---|---|
| Research Development | 2.45 million | 2.38 million | 3.27 million | 2.35 million | 2.47 million |
| Income Before Tax | -5.26 million | -6.53 million | -11.07 million | -5.93 million | -7.96 million |
| Selling General Administrative | 10.96 million | 10.94 million | 9.21 million | 10.07 million | 9.82 million |
| Gross Profit | 15 million | 13.28 million | 14.95 million | 14.01 million | 11.84 million |
| Ebit | 1.63 million | -3.68 million | -1.16 million | -2.05 million | -4.09 million |
| Operating Income | -2.04 million | -3.68 million | -1.16 million | -2.05 million | -4.09 million |
| Income Tax Expense | -45000 | 17000 | 4000 | 8000 | -8000 |
| Total Revenue | 19.63 million | 17.25 million | 17.97 million | 18.39 million | 16.15 million |
| Cost of Revenue | 4.63 million | 3.97 million | 3.02 million | 4.38 million | 4.31 million |
| Total Other Income Expense Net | N/A | -2.85 million | -9.91 million | -3.88 million | -3.87 million |
| Net Income From Continuing Operations | -5.21 million | -6.55 million | -11.07 million | -5.94 million | -7.95 million |
| Net Income Applicable to Common Shares | -5.21 million | -6.55 million | -11.07 million | -5.94 million | -7.95 million |
Cash Flow:
| Date | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | 69.44 million | 12.6 million | -429000 |
| Change to Liabilities | N/A | 1.25 million | 2.04 million | -102000 | -5.6 million |
| Total Cash Flow from Investing Activities | N/A | N/A | 69.44 million | 12.58 million | -450000 |
| Net Borrowings | N/A | -53000 | -48.7 million | -98000 | N/A |
| Total Cash Flow from Financial Activities | N/A | -38000 | -48.7 million | -82000 | N/A |
| Change to Operating Activities | N/A | -2.14 million | 852000 | 945000 | 1.39 million |
| Change in Cash | N/A | -7.46 million | 15.09 million | 2 million | -7.39 million |
| Total Cash from Operating Activities | N/A | -7.4 million | -5.64 million | -10.5 million | -6.94 million |
| Depreciation | N/A | 3.68 million | 3.67 million | 3.68 million | 3.68 million |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | -4.56 million | -811000 | -8.44 million | 1.19 million |
| Change to Account Receivables | N/A | 1.31 million | 503000 | -14000 | 1.05 million |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Net Income | N/A | -393000 | -825000 | -630000 | -698000 |
| Capital Expenditures | N/A | N/A | 3000 | 18000 | 21000 |
Balance Sheet:
| Date | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 289.86 million | 287.53 million | 289.37 million | 337.12 million | 337.43 million |
| Total Stockholder Equity | -73.96 million | -69.22 million | -63.27 million | -52.48 million | -47.25 million |
| Other Current Liabilities | N/A | 16.12 million | 1.25 million | 16.36 million | 14.91 million |
| Total Assets | 215.91 million | 218.31 million | 226.1 million | 284.65 million | 290.18 million |
| Common Stock | 11000 | 11000 | 11000 | 11000 | 11000 |
| Other Current Assets | N/A | N/A | N/A | N/A | 6.57 million |
| Retained Earnings | -917.22 million | -912.01 million | -905.46 million | -894.39 million | -888.45 million |
| Other Liabilities | 2.77 million | 3.06 million | 3.38 million | 3.74 million | 3.98 million |
| Other Assets | N/A | 621000 | N/A | 208000 | 208000 |
| Cash | 32.85 million | 32.65 million | 40.11 million | 25.02 million | 23.02 million |
| Total Current Liabilities | 227.79 million | 225.15 million | 226.67 million | 225.48 million | 38.97 million |
| Other Stockholder Equity | 108000 | -35000 | -6000 | 201000 | -21000 |
| Property, Plant & Equipment | 1.13 million | 1.37 million | 1.57 million | 1.63 million | 1.82 million |
| Total Current Assets | 97.85 million | 96.8 million | 101.17 million | 156.02 million | 157.72 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | -190.88 million | -188.74 million | -186.64 million | -179.27 million | -177.68 million |
| Short Term Investments | N/A | N/A | N/A | 69.34 million | 81.63 million |
| Long Term Debt | 58.91 million | 58.72 million | 58.54 million | 107.01 million | 294.28 million |
| Inventory | 33.94 million | 33.68 million | 30.01 million | 30.11 million | 21.95 million |
| Accounts Payable | 11.02 million | 7.73 million | 6.16 million | 3.8 million | 3.62 million |
VIVUS, Inc (VVUS) Chart:
VIVUS, Inc (VVUS) News:
Below you will find a list of latest news for VIVUS, Inc (VVUS) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
VIVUS, Inc (VVUS) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
VIVUS, Inc (VVUS) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-19 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/881524/000110465920074978/0001104659-20-074978-index.htm |
| 2018-09-25 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/881524/000000000018030176/0000000000-18-030176-index.htm |
| 2020-04-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/881524/000091957420002903/0000919574-20-002903-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/881524/000103738919000260/0001037389-19-000260-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/881524/000103738920000129/0001037389-20-000129-index.htm |
| 2019-04-17 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/881524/000104746919002314/0001047469-19-002314-index.htm |
| 2020-04-29 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/881524/000104746920002715/0001047469-20-002715-index.htm |
| 2020-06-08 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/881524/000104746920003425/0001047469-20-003425-index.htm |
| 2020-06-09 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/881524/000104746920003427/0001047469-20-003427-index.htm |
| 2020-06-19 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/881524/000104746920003720/0001047469-20-003720-index.htm |
| 2019-01-18 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/881524/000106299319000281/0001062993-19-000281-index.htm |
| 2020-02-04 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/881524/000106299320000433/0001062993-20-000433-index.htm |
| 2018-09-14 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/881524/000110465918056915/0001104659-18-056915-index.htm |
| 2018-09-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465918057911/0001104659-18-057911-index.htm |
| 2018-09-25 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/881524/000110465918058438/0001104659-18-058438-index.htm |
| 2018-09-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465918058581/0001104659-18-058581-index.htm |
| 2018-10-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465918062507/0001104659-18-062507-index.htm |
| 2018-10-24 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/881524/000110465918063663/0001104659-18-063663-index.htm |
| 2018-10-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465918064283/0001104659-18-064283-index.htm |
| 2018-11-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465918065423/0001104659-18-065423-index.htm |
| 2018-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465918066319/0001104659-18-066319-index.htm |
| 2018-11-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465918070009/0001104659-18-070009-index.htm |
| 2018-12-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465918072543/0001104659-18-072543-index.htm |
| 2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919000983/0001104659-19-000983-index.htm |
| 2019-01-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919001680/0001104659-19-001680-index.htm |
| 2019-01-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919003465/0001104659-19-003465-index.htm |
| 2019-02-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919005518/0001104659-19-005518-index.htm |
| 2019-02-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919010674/0001104659-19-010674-index.htm |
| 2019-03-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919011979/0001104659-19-011979-index.htm |
| 2019-03-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919014715/0001104659-19-014715-index.htm |
| 2019-04-17 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/881524/000110465919021959/0001104659-19-021959-index.htm |
| 2019-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919025312/0001104659-19-025312-index.htm |
| 2019-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919025322/0001104659-19-025322-index.htm |
| 2019-05-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919026819/0001104659-19-026819-index.htm |
| 2019-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919029534/0001104659-19-029534-index.htm |
| 2019-05-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919031894/0001104659-19-031894-index.htm |
| 2019-05-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919032030/0001104659-19-032030-index.htm |
| 2019-06-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919034529/0001104659-19-034529-index.htm |
| 2019-06-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919037654/0001104659-19-037654-index.htm |
| 2019-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919043851/0001104659-19-043851-index.htm |
| 2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919044301/0001104659-19-044301-index.htm |
| 2019-08-06 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/881524/000110465919044321/0001104659-19-044321-index.htm |
| 2019-08-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919045101/0001104659-19-045101-index.htm |
| 2019-08-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919046600/0001104659-19-046600-index.htm |
| 2019-08-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919047376/0001104659-19-047376-index.htm |
| 2019-09-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919048832/0001104659-19-048832-index.htm |
| 2019-10-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919052859/0001104659-19-052859-index.htm |
| 2019-10-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919053186/0001104659-19-053186-index.htm |
| 2019-10-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919055084/0001104659-19-055084-index.htm |
| 2019-10-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919056671/0001104659-19-056671-index.htm |
| 2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919060055/0001104659-19-060055-index.htm |
| 2019-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919061682/0001104659-19-061682-index.htm |
| 2019-11-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919065650/0001104659-19-065650-index.htm |
| 2019-12-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919073582/0001104659-19-073582-index.htm |
| 2019-12-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465919076980/0001104659-19-076980-index.htm |
| 2019-12-31 | 8-A12B | Registration of securities [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/881524/000110465919076984/0001104659-19-076984-index.htm |
| 2020-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465920001780/0001104659-20-001780-index.htm |
| 2020-01-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465920009314/0001104659-20-009314-index.htm |
| 2020-02-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465920011000/0001104659-20-011000-index.htm |
| 2020-02-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465920022580/0001104659-20-022580-index.htm |
| 2020-02-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465920023876/0001104659-20-023876-index.htm |
| 2020-03-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465920027488/0001104659-20-027488-index.htm |
| 2020-03-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465920028540/0001104659-20-028540-index.htm |
| 2020-03-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465920030185/0001104659-20-030185-index.htm |
| 2020-03-06 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/881524/000110465920030264/0001104659-20-030264-index.htm |
| 2020-03-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465920030272/0001104659-20-030272-index.htm |
| 2020-03-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465920040821/0001104659-20-040821-index.htm |
| 2020-04-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465920041912/0001104659-20-041912-index.htm |
| 2020-04-02 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/881524/000110465920042353/0001104659-20-042353-index.htm |
| 2020-04-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465920042568/0001104659-20-042568-index.htm |
| 2020-04-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465920043012/0001104659-20-043012-index.htm |
| 2020-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465920055004/0001104659-20-055004-index.htm |
| 2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465920057425/0001104659-20-057425-index.htm |
| 2020-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465920058855/0001104659-20-058855-index.htm |
| 2020-06-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465920068654/0001104659-20-068654-index.htm |
| 2020-06-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465920074975/0001104659-20-074975-index.htm |
| 2020-06-19 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/881524/000110465920074978/0001104659-20-074978-index.htm |
| 2020-07-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465920081778/0001104659-20-081778-index.htm |
| 2020-07-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000110465920082914/0001104659-20-082914-index.htm |
| 2020-08-17 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB | https://www.sec.gov/Archives/edgar/data/881524/000110465920096093/0001104659-20-096093-index.htm |
| 2018-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329218000962/0001123292-18-000962-index.htm |
| 2018-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329218000964/0001123292-18-000964-index.htm |
| 2018-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329218000995/0001123292-18-000995-index.htm |
| 2018-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329218000997/0001123292-18-000997-index.htm |
| 2018-10-29 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329218001039/0001123292-18-001039-index.htm |
| 2018-10-29 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329218001040/0001123292-18-001040-index.htm |
| 2018-10-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329218001041/0001123292-18-001041-index.htm |
| 2018-10-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329218001042/0001123292-18-001042-index.htm |
| 2018-10-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329218001043/0001123292-18-001043-index.htm |
| 2018-10-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329218001044/0001123292-18-001044-index.htm |
| 2018-10-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329218001045/0001123292-18-001045-index.htm |
| 2018-10-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329218001046/0001123292-18-001046-index.htm |
| 2018-11-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329218001056/0001123292-18-001056-index.htm |
| 2018-11-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329218001066/0001123292-18-001066-index.htm |
| 2018-11-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329218001067/0001123292-18-001067-index.htm |
| 2019-01-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329219000194/0001123292-19-000194-index.htm |
| 2019-01-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329219000196/0001123292-19-000196-index.htm |
| 2019-01-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329219000198/0001123292-19-000198-index.htm |
| 2019-01-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329219000200/0001123292-19-000200-index.htm |
| 2019-01-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329219000203/0001123292-19-000203-index.htm |
| 2019-01-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329219000204/0001123292-19-000204-index.htm |
| 2019-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329219000414/0001123292-19-000414-index.htm |
| 2019-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329219000416/0001123292-19-000416-index.htm |
| 2019-04-10 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329219000618/0001123292-19-000618-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329219000772/0001123292-19-000772-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329219000774/0001123292-19-000774-index.htm |
| 2019-11-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329219001281/0001123292-19-001281-index.htm |
| 2019-11-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329219001282/0001123292-19-001282-index.htm |
| 2020-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329220000196/0001123292-20-000196-index.htm |
| 2020-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329220000197/0001123292-20-000197-index.htm |
| 2020-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329220000198/0001123292-20-000198-index.htm |
| 2020-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329220000199/0001123292-20-000199-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329220000322/0001123292-20-000322-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329220000323/0001123292-20-000323-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329220000324/0001123292-20-000324-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329220000325/0001123292-20-000325-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329220000326/0001123292-20-000326-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/881524/000112329220000327/0001123292-20-000327-index.htm |
| 2020-04-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/881524/000121390020008982/0001213900-20-008982-index.htm |
| 2020-08-11 | 25-NSE | Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or ret | https://www.sec.gov/Archives/edgar/data/881524/000135445720000405/0001354457-20-000405-index.htm |
| 2019-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/881524/000141057819000417/0001410578-19-000417-index.htm |
| 2020-04-01 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/881524/000153561020000084/0001535610-20-000084-index.htm |
| 2018-11-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/881524/000155837018008255/0001558370-18-008255-index.htm |
| 2019-02-26 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/881524/000155837019001077/0001558370-19-001077-index.htm |
| 2019-04-30 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/881524/000155837019003605/0001558370-19-003605-index.htm |
| 2019-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/881524/000155837019007219/0001558370-19-007219-index.htm |
| 2019-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/881524/000155837019009961/0001558370-19-009961-index.htm |
| 2020-03-03 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/881524/000155837020001956/0001558370-20-001956-index.htm |
| 2020-05-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/881524/000155837020005397/0001558370-20-005397-index.htm |
| 2018-09-27 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/881524/999999999518002486/9999999995-18-002486-index.htm |
| 2018-12-21 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/881524/999999999718009640/9999999997-18-009640-index.htm |
| 2019-03-19 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/881524/999999999719001414/9999999997-19-001414-index.htm |
| 2019-03-19 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/881524/999999999719001416/9999999997-19-001416-index.htm |
| 2019-11-14 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/881524/999999999719007557/9999999997-19-007557-index.htm |
| 2019-12-13 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/881524/999999999719007878/9999999997-19-007878-index.htm |
| 2020-03-12 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/881524/999999999720001217/9999999997-20-001217-index.htm |
| 2020-04-24 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/881524/999999999720002110/9999999997-20-002110-index.htm |
| 2020-07-23 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/881524/999999999720004142/9999999997-20-004142-index.htm |
| 2020-08-03 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/881524/999999999720004260/9999999997-20-004260-index.htm |
VIVUS, Inc (VVUS) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of VIVUS, Inc (VVUS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 709%Institutional Ownership: 1907%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2018-11-06 | Mark K Oki | Chief Financial Officer & CAO | Buy | 10,000.00 | 4.07 | 40,700.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/881524/000112329218001056/0001123292-18-001056-index.htm |
| 2018-11-14 | Mark K Oki | Chief Financial Officer & CAO | Buy | 700.00 | 2.71 | 1,897.00 | 10,700.00 | https://www.sec.gov/Archives/edgar/data/881524/000112329218001066/0001123292-18-001066-index.htm |
| 2019-05-14 | Mark K Oki | SVP, CFO, CAO | Buy | 700.00 | 2.84 | 1,988.00 | 11,400.00 | https://www.sec.gov/Archives/edgar/data/881524/000112329219000774/0001123292-19-000774-index.htm |
| 2019-11-14 | Mark K Oki | SVP, CFO, CAO | Buy | 700.00 | 2.38 | 1,666.00 | 12,100.00 | https://www.sec.gov/Archives/edgar/data/881524/000112329219001282/0001123292-19-001282-index.htm |
| 2019-02-28 | Eric W Roberts | Director | Buy | 8,500.00 | 4.82 | 40,981.90 | 16,660.00 | https://www.sec.gov/Archives/edgar/data/881524/000112329219000416/0001123292-19-000416-index.htm |
| 2019-03-01 | John P. Amos | Chief Executive Officer | Buy | 11,000.00 | 4.85 | 53,384.10 | 1,719,500.00 | https://www.sec.gov/Archives/edgar/data/881524/000112329219000414/0001123292-19-000414-index.htm |
| 2018-10-01 | Allan Shaw | Director | Buy | 139.00 | 6,432.00 | https://www.sec.gov/Archives/edgar/data/881524/000112329218000997/0001123292-18-000997-index.htm | ||
| 2018-11-14 | Santosh T Varghese | Chief Medical Officer | Buy | 700.00 | 2.71 | 1,897.00 | 7,842.00 | https://www.sec.gov/Archives/edgar/data/881524/000112329218001067/0001123292-18-001067-index.htm |
| 2018-10-01 | Eric W Roberts | Director | Buy | 139.00 | 8,203.00 | https://www.sec.gov/Archives/edgar/data/881524/000112329218000995/0001123292-18-000995-index.htm | ||
| 2019-05-14 | Santosh T Varghese | Chief Medical Officer | Buy | 700.00 | 2.84 | 1,988.00 | 8,542.00 | https://www.sec.gov/Archives/edgar/data/881524/000112329219000772/0001123292-19-000772-index.htm |
| 2019-11-14 | Santosh T Varghese | Chief Medical Officer | Buy | 700.00 | 2.38 | 1,666.00 | 9,242.00 | https://www.sec.gov/Archives/edgar/data/881524/000112329219001281/0001123292-19-001281-index.htm |